Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

The T follicular helper/T follicular helper regulatory pathway in FVIII immune responses in mice

Weiqing Jing, Jocelyn A Schroeder, Saurabh Kumar, Juan Chen, Yuanhua Cai, Lynn M Malec, Alexander L. Dent, Weiguo Cui, Qizhen Shi

Blood blood.2025029470.

https://doi.org/10.1182/blood.2025029470

Published: 2025

Includes: Supplemental data

Journal Articles

Emicizumab for the Treatment of Acquired Hemophilia a: A Multicenter US Case Series

Jacqueline N. Poston, Kadhim Al-Banaa, Annette von Drygalski, Aric D. Parnes, Christopher E Walsh, James F Wu, Craig M. Kessler, Maissaa Janbain, Lynn M Malec, Rebecca Kruse-Jarres

Blood (2021) 138 (Supplement 1): 496.

https://doi.org/10.1182/blood-2021-148040

Published: 2021

Journal Articles

ATHN Transcends: A Natural History Cohort Study of the Safety, Effectiveness and Practice of Treatment in People with Non-Neoplastic Hematologic Disorders

Lynn M Malec, Nikki Hirsh, Carrie O'Neill, Crystal Watson, Michael Recht

Blood (2021) 138 (Supplement 1): 4242.

https://doi.org/10.1182/blood-2021-148209

Published: 2021

Journal Articles

Perioperative Outcomes Associated with Inhibitor Status in Patients with Hemophilia - a Retrospective Cohort Study

Omotola O. Olasupo, Charles Nakar, Alfonso Iorio, Craig Haddix, Thushara Mathew, Lynn M Malec, Davide Matino, Lawrence Mbuagbaw, Jean-Eric Tarride, Amy D. Shapiro

Blood (2021) 138 (Supplement 1): 4990.

https://doi.org/10.1182/blood-2021-147550

Published: 2021

Journal Articles

U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPs Study): Association between Family History and Age of Diagnosis

Courtney D Thornburg, MD, Kenneth D Friedman, MD, Michael F Guerrera, MD, Chunla He, Lynn M Malec, MD, Mindy L Simpson, MD, Michael D Tarantino, MD, H. Marijke Van Den Berg, Crystal Watson, BS, Shannon L Carpenter, MD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-138748

Published: 2020

Journal Articles

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia a and B

Tyler W. Buckner, MDMSc, Shannon L Carpenter, MD, Stacy E. Croteau, MD, Adam Cuker, MDMS, Nabil Daoud, MA, Christine L Kempton, MDMSc, Lynn M Malec, MD, Thomas W. McLean, MD, Leslie J. Raffini, MD, Janice M Staber, MD, Michael Wang, MD, Crystal Watson, BS, Ayesha Zia, MD, Michael Recht, MD PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-137696

Published: 2020

Journal Articles

Inhibit Clinical Trials Platform to Prevent and Eradicate Inhibitors: Feasibility Survey of Current Prophylaxis and Immune Tolerance Practices

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-136814

Published: 2020

Journal Articles

Spontaneous Bleeding and Poor Bleeding Response with Extended Half-Life Factor IX Products: A Survey of Select US and Canadian Hemophilia Treatment Centers

Lynn M Malec, MD, Stacy E. Croteau, Michael Callaghan, MD, Davide Matino, MD MSc, Kenneth Dale Friedman, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 2407.

https://doi.org/10.1182/blood-2019-126196

Published: 2019

Journal Articles

Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial

Blood (2019) 134 (Supplement_1): 1130.

https://doi.org/10.1182/blood-2019-124234

Published: 2019

Journal Articles

Analysis of Bleeding and Treatment Patterns in Children and Adolescents before and after Von Willebrand Disease Diagnosis Using Data from a US Medical Claims Database

Jonathan C. Roberts, Lynn M Malec, MD, Imrran Halari, Sarah Hale, Abiola Oladapo, Robert Sidonio

Blood (2019) 134 (Supplement_1): 2117.

https://doi.org/10.1182/blood-2019-122164

Published: 2019

Journal Articles

Adoption of Prophylaxis in the United States in the Era of Extended Half-Life Factor Concentrates

Lynn M. Malec, MD, Gilbert C. White, MD, Stacy E. Croteau, MD, Dunlei Cheng, PhD, Margaret V. Ragni, MD MPH

Blood (2018) 132 (Supplement 1): 2467.

https://doi.org/10.1182/blood-2018-99-115231

Published: 2018

Journal Articles

Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United States

Lynn M. Malec, MD, Char M Witmer, MDMSCE, Julie Jaffray, MD, Peter A. Kouides, MD, Kristina M. Haley, DO, Robert F. Sidonio, Jr., MD, Dunlei Cheng, PhD, Thomas C. Abshire, MD, Gilbert C. White, MD, Margaret V. Ragni, MD MPH

Blood (2018) 132 (Supplement 1): 1195.

https://doi.org/10.1182/blood-2018-99-113956

Published: 2018

Journal Articles

Copper Deficiency

Allison Close, MD, Lynn M. Malec, MD MSc

Blood (2017) 130 (Supplement 1): 4742.

https://doi.org/10.1182/blood.V130.Suppl_1.4742.4742

Published: 2017

Journal Articles

Observational Study of Recombinant Factor-VIII-Fc, Eloctate, in Hemophilia Patients with and without Inhibitors

Patrick T. Ebbert, BS, Margaret V. Ragni, MD MPH, Frederico Xavier, MD MS, Lynn M. Malec, MD, Craig D. Seaman

Blood (2017) 130 (Supplement 1): 3689.

https://doi.org/10.1182/blood.V130.Suppl_1.3689.3689

Published: 2017

Journal Articles

Durability of ITI Utilizing Rfviiifc

Margaret V. Ragni, MD, Lynn M. Malec, MD, Janna M. Journeycake, MD

Blood (2016) 128 (22): 3793.

https://doi.org/10.1182/blood.V128.22.3793.3793

Published: 2016

Journal Articles

Von Willebrand Factor to Prevent Postpartum Hemorrhage

Nicoletta Machin, MD, Margaret V. Ragni, MD, Andra H. James, MD MPH, Craig D. Seaman, MD, Lynn M. Malec, MD, Craig M. Kessler, MD, Barbara Konkle, MD, Peter Kouides, MD, Anne T. Neff, MD, Claire S. Philipp, MD, Maria M. Brooks, PhD

Blood (2016) 128 (22): 1400.

https://doi.org/10.1182/blood.V128.22.1400.1400

Published: 2016

Journal Articles

Immune Tolerance Induction Using Rfviiifc (Eloctate)

Lynn M. Malec, MD MS, Margaret V Ragni, Janna M. Journeycake, MD, Michelle Alabek, MS, CGC

Blood (2015) 126 (23): 3531.

https://doi.org/10.1182/blood.V126.23.3531.3531

Published: 2015

Journal Articles

Regulatory T Cell Response to Factor VIII in Mothers of Children with Hemophilia Inhibitors

Margaret V. Ragni, MD MPH, Lynn M. Malec, MD, Craig D. Seaman, MD, Lisa Butterfield, PhD

Blood (2015) 126 (23): 3512.

https://doi.org/10.1182/blood.V126.23.3512.3512

Published: 2015

Journal Articles

Von Willebrand Factor for Menorrhagia: A Survey and Literature Review

Nicoletta Machin, MD, Margaret V. Ragni, MD MPH, Lynn M. Malec, MD, Donald Brambilla, PhD, Thomas Coyle, MD, Joanna A. Davis, MD, Annette Drygalski, Andra H James, MD MPH, Shawn M Jobe, MD PhD, Barbara A. Konkle, MD, Peter Kouides, MD, Philip Kuriakose, MD, Alice D. Ma, MD, Elaine M. Majerus, MD PhD, Danielle Nance, MD, Anne T. Neff, MD, Claire S. Philipp, MD, Tzu-Fei Wang, MD, Hassan M. Yaish, MD

Blood (2015) 126 (23): 4694.

https://doi.org/10.1182/blood.V126.23.4694.4694

Published: 2015

Journal Articles

Thrombin Generation and Bleeding in Hemophilia Inhibitor Patients during Immune Tolerance Induction

Margaret V. Ragni, MD MPH, Donna DiMichele, MD, Charles R.M. Hay, MD FRCP, FRCPath, Lynn M. Malec, MD, Craig D. Seaman, MD, Jonathan Yabes, PhD, Jie Li, MS, Saulius Butenas, PhD, Kathleen Brumel-Ziedins, PhD

Blood (2014) 124 (21): 1514.

https://doi.org/10.1182/blood.V124.21.1514.1514

Published: 2014

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

The T follicular helper/T follicular helper regulatory pathway in FVIII immune responses in mice

Emicizumab for the Treatment of Acquired Hemophilia a: A Multicenter US Case Series

ATHN Transcends: A Natural History Cohort Study of the Safety, Effectiveness and Practice of Treatment in People with Non-Neoplastic Hematologic Disorders

Perioperative Outcomes Associated with Inhibitor Status in Patients with Hemophilia - a Retrospective Cohort Study

U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPs Study): Association between Family History and Age of Diagnosis

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia a and B

Inhibit Clinical Trials Platform to Prevent and Eradicate Inhibitors: Feasibility Survey of Current Prophylaxis and Immune Tolerance Practices

Spontaneous Bleeding and Poor Bleeding Response with Extended Half-Life Factor IX Products: A Survey of Select US and Canadian Hemophilia Treatment Centers

Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial

Analysis of Bleeding and Treatment Patterns in Children and Adolescents before and after Von Willebrand Disease Diagnosis Using Data from a US Medical Claims Database

Adoption of Prophylaxis in the United States in the Era of Extended Half-Life Factor Concentrates

Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United States

Copper Deficiency

Observational Study of Recombinant Factor-VIII-Fc, Eloctate, in Hemophilia Patients with and without Inhibitors

Durability of ITI Utilizing Rfviiifc

Von Willebrand Factor to Prevent Postpartum Hemorrhage

Immune Tolerance Induction Using Rfviiifc (Eloctate)

Regulatory T Cell Response to Factor VIII in Mothers of Children with Hemophilia Inhibitors

Von Willebrand Factor for Menorrhagia: A Survey and Literature Review

Thrombin Generation and Bleeding in Hemophilia Inhibitor Patients during Immune Tolerance Induction

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only